Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Annual Brain Magnetic Resonance Imaging Surveillance for Detection of Brain Metastasis and Survival Outcomes in Patients With Lung Cancer: A Nationwide Sequential Target Trial Emulation Study

NCT07646041 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT07646041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07646041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Annual Brain Magnetic Resonance Imaging Surveillance for Detection of Brain Metastasis and Survival Outcomes in Patients With Lung Cancer: A Nationwide Sequential Target Trial Emulation Study
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
January 1, 2012
Completion date
December 31, 2021
Enrollment
229,323 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastasases, lung cancer, mri, surveillance